This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: K.u. Leuven Research & Development. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Arthur Van Aerschot: Innovator in HIV Research
Introduction
Arthur Van Aerschot is a notable inventor based in Heist-op-den-Berg, Belgium. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that inhibit HIV. His work is characterized by a strong focus on biological activity against viral infections.
Latest Patents
Arthur Van Aerschot holds a patent for "HIV inhibiting N-aminoimidazole derivatives." This patent describes a range of N-aminoimidazole or N-aminoimidazolethione derivatives, including their pharmaceutically acceptable salts, tautomers, isomers, esters, or glycosylation products. The compounds are represented by a specific general formula and are noted for their potential biological activity, especially against viral infections.
Career Highlights
Arthur is affiliated with K.U. Leuven Research & Development, where he has been involved in groundbreaking research. His work has contributed to the understanding and potential treatment of HIV, showcasing his commitment to advancing medical science.
Collaborations
He has collaborated with esteemed colleagues such as Erik De Clercq and Piet Herdewijn. These partnerships have further enhanced the impact of his research in the field of virology.
Conclusion
Arthur Van Aerschot is a prominent figure in the fight against HIV, with a patent that highlights his innovative approach to developing effective antiviral agents. His contributions continue to influence the pharmaceutical landscape and offer hope for improved treatments.